Your browser doesn't support javascript.
loading
Relationship between Chemotherapy-Induced Diarrhea and Intestinal Microbiome Composition.
Kawasaki, Yuka; Kakimoto, Kazuki; Tanaka, Yasuyoshi; Shimizu, Hikaru; Nishida, Koji; Numa, Keijiro; Kinoshita, Naohiko; Tatsumi, Yoshihiro; Nakazawa, Kei; Koshiba, Ryoji; Hirata, Yuki; Ota, Kazuhiro; Sakiyama, Naokuni; Terazawa, Tetsuji; Takeuchi, Toshihisa; Miyazaki, Takako; Goto, Masahiro; Yokota, Haruka; Makizaki, Yutaka; Tanaka, Yoshiki; Nakajima, Shunji; Ohno, Hiroshi; Higuchi, Kazuhide; Nakamura, Shiro; Nishikawa, Hiroki.
Affiliation
  • Kawasaki Y; 2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Kakimoto K; 2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Tanaka Y; 2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Shimizu H; 2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Nishida K; 2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Numa K; 2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Kinoshita N; 2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Tatsumi Y; 2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Nakazawa K; 2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Koshiba R; 2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Hirata Y; 2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Ota K; 2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Sakiyama N; 2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Terazawa T; 2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Takeuchi T; 2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Miyazaki T; 2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Goto M; 2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Yokota H; R&D Center, Biofermin Pharmaceutical Co., Ltd., Kobe, Japan.
  • Makizaki Y; R&D Center, Biofermin Pharmaceutical Co., Ltd., Kobe, Japan.
  • Tanaka Y; R&D Center, Biofermin Pharmaceutical Co., Ltd., Kobe, Japan.
  • Nakajima S; R&D Center, Biofermin Pharmaceutical Co., Ltd., Kobe, Japan.
  • Ohno H; R&D Center, Biofermin Pharmaceutical Co., Ltd., Kobe, Japan.
  • Higuchi K; 2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Nakamura S; 2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Nishikawa H; 2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
Digestion ; 104(5): 357-369, 2023.
Article in En | MEDLINE | ID: mdl-37231829
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gastrointestinal Microbiome / Antineoplastic Agents Type of study: Observational_studies Limits: Humans Language: En Journal: Digestion Year: 2023 Type: Article Affiliation country: Japan
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gastrointestinal Microbiome / Antineoplastic Agents Type of study: Observational_studies Limits: Humans Language: En Journal: Digestion Year: 2023 Type: Article Affiliation country: Japan